Learn about polymyalgia rheumatica, temporal arteritis, their symptoms, causes, and treatment options to manage pain, ...
Topline data were announced from a phase 3 trial evaluating secukinumab in patients with polymyalgia rheumatica.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback